Summary
The Defense Logistics Agency (DLA) is planning to issue a national requirements contract for Valsartan tablets in multiple strengths and package sizes to be procured as commercial items under FAR Part 12. The acquisition will be an unrestricted, fully competitive, firm-fixed-price requirements contract with a one-year base and four one-year options to establish a national supply source for DoD, VA, IHS, and Bureau of Prisons customers via DLA and VA prime vendor programs. The solicitation is projected to be posted to DIBBS and SAM.gov in June 2026 and lists Ryan Guarnere as the primary point of contact.